Health Care
Sector overview · 4 tickers · 29 news · last 90 days
90-day window
with at least one scored article
articles linked to sector tickers
Sentiment scores computed by AI · Not investment advice.
Sector sentiment trend
Daily relevance-weighted sentiment, 7-day trailing average across all sector tickers.
Top tickers · 4
Recent news · 29
- CNBC5/1/2026, 4:15:27 PMCramer says Apple and Eli Lilly still have room to run after post-earnings rallies
CNBC's Jim Cramer, via the Investing Club Morning Meeting, expressed continued bullishness on Apple and Eli Lilly following their recent post-earnings price rallies. The commentary suggests both stocks have further upside potential, though no new fundamental data or catalysts were presented. This is opinion-based commentary from a media personality rather than a new corporate or analyst development.
Sentiment 0.30LLY - CNBC4/27/2026, 7:09:28 PMBiggest winner of the amended Microsoft-OpenAI deal — plus, mixed news for Eli Lilly
CNBC's Investing Club "Homestretch" segment covers the amended Microsoft-OpenAI deal and mixed news for Eli Lilly. The article is a brief afternoon trading update newsletter with no detailed disclosures on the Microsoft-OpenAI restructuring or specifics on Eli Lilly's news. No substantive new information is provided beyond the headline references.
Sentiment 0.10LLY - The Motley Fool4/24/2026, 3:21:44 PMThe FDVV ETF Delivers Higher 5-Year Growth Than the HDV ETF
The Fidelity High Dividend ETF (FDVV) returned $1,883 on a $1,000 investment over 5 years, outpacing the iShares Core High Dividend ETF (HDV) at $1,659, driven by FDVV's heavier weighting in technology and financials versus HDV's energy and defensive tilt. FDVV posted a 66.5% 3-year return compared to HDV's 43.9%, though both trailed the S&P 500's 79% gain over the same period. FDVV carries a higher expense ratio despite comparable dividend yields between the two funds.
Sentiment 0.10JNJ - Yahoo4/24/2026, 3:07:52 PMA Look At UnitedHealth Group (UNH) Valuation As Q1 2026 Beat And Guidance Hike Drive Fresh Momentum
UnitedHealth Group reported Q1 2026 results that beat analyst expectations and raised its full-year adjusted earnings guidance. The stock has posted a 12.1% gain over the past 7 days and 30.2% over the past month following the announcement, though the 1-year total shareholder return remains down 14.1%. The article focuses on valuation analysis in the context of this renewed price momentum.
Sentiment 0.60UNH - Yahoo4/24/2026, 3:05:29 PMHow Expanding GLP‑1 Offerings and Partnering With LillyDirect At Hims & Hers Health (HIMS) Has Changed Its Investment Story
Hims & Hers Health has expanded its platform to allow clinicians to prescribe Eli Lilly GLP-1 treatments (Zepbound vials, KwikPen, and Foundayo) fulfilled via LillyDirect, while also broadening access to Novo Nordisk therapies. The company additionally acquired a facility to strengthen peptide capabilities ahead of an FDA review on compounding. These moves deepen HIMS's role in prescription weight management and could materially shift its product mix.
Sentiment 0.55LLY - Yahoo4/24/2026, 3:01:04 PMJim Cramer Says UNH at $354 Is a Steal — Here’s Why the Math Backs Him Up
Jim Cramer featured UnitedHealth Group (UNH) on Mad Money (April 21), calling the stock a buying opportunity at $354, citing a returning CEO, a Q1 earnings beat, and a price well below prior highs. The article presents a bullish case based on valuation and recent operational recovery. No independent financial analysis or counter-thesis is provided beyond Cramer's commentary.
Sentiment 0.55UNH - Yahoo4/24/2026, 3:00:00 PMEli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims
Eli Lilly's new oral GLP-1 weight-loss drug is reportedly seeing prescription volumes trail Novo Nordisk's oral Wegovy. JPMorgan has initiated coverage on Hims & Hers Health. Regeneron is offering a new hearing-loss therapy at no cost.
Sentiment -0.10LLY - Yahoo4/24/2026, 2:41:28 PMUnitedHealth Group (UNH): Vertical Integration Resilience Woos Safe Investors
UnitedHealth Group (UNH) ranks 10th on a list of 15 safe stocks for beginners, cited for its vertical integration and operational efficiency initiatives. The company recently announced it will eliminate most medical prior authorizations for rural providers. The article frames this move as a positive signal for investors focused on stability.
Sentiment 0.30UNH - Yahoo4/24/2026, 2:18:00 PMSpherix Global Insights Finds Specialty Split in Perceptions of Direct-to-Patient Platforms for Obesity Treatment
Spherix Global Insights released a report finding high adoption rates among physicians for both Eli Lilly's LillyDirect and Novo Nordisk's NovoCare direct-to-patient platforms for obesity treatment, though workflow differences are driving a specialty-based split in platform preference. LillyDirect launched in January 2024 and NovoCare in March 2025, with both now increasingly integrated into physician workflows. The report highlights evolving competitive dynamics in the direct-to-patient obesity drug distribution channel.
Sentiment 0.10LLY - Yahoo4/24/2026, 2:10:06 PMBattle Of The Weight-Loss Pills Continues With A Shocking Twist
Eli Lilly's stock declined after data showed Novo Nordisk's oral Wegovy outperforming Lilly's newly launched weight-loss pill, Foundayo. The comparison highlights intensifying competition in the oral GLP-1 weight-loss drug market. Both companies are vying for market share in the rapidly growing obesity treatment segment.
Sentiment -0.60LLY - Yahoo4/24/2026, 2:03:01 PMEli Lilly Shares Dip Despite Stable Growth in GLP-1 Prescriptions
Eli Lilly shares fell approximately 2% following the release of mixed weekly prescription data for its GLP-1 drug portfolio. IQVIA data cited by Morgan Stanley showed Mounjaro total prescriptions rose to ~758,400 for the week ending April 17, 2026, up from ~749,500 the prior week, with new prescriptions also ticking higher to ~367,900. Despite the sequential growth in Mounjaro volumes, the broader mixed trends across the GLP-1 portfolio weighed on the stock.
Sentiment -0.30LLY - Yahoo4/24/2026, 1:37:23 PMLilly’s New Obesity Pill Off to Slow Start in Race With Novo
Eli Lilly's new oral weight-loss drug Foundayo is showing slow early prescription uptake, according to new prescription data. The sluggish start highlights the challenge Lilly faces in competing with Novo Nordisk in the obesity drug market. The data represents an early indicator only and does not reflect long-term commercial trajectory.
Sentiment -0.45LLY - SeekingAlpha4/24/2026, 1:17:53 PMJ&J to buy private MedTech Atraverse to boost cardiac ablation portfolio
Johnson & Johnson has announced plans to acquire private medical technology company Atraverse, according to a SeekingAlpha report. The deal is aimed at strengthening J&J's cardiac ablation portfolio within its MedTech segment. Atraverse is a private company, so no publicly traded target ticker is involved.
Sentiment 0.40JNJ - CNBC4/24/2026, 12:08:28 PMStocks making the biggest moves midday: Intel, AMD, Charter, Hims & Hers, Eli Lilly and more
CNBC highlights stocks with the largest midday price moves, including Intel, AMD, Charter, Hims & Hers, and Eli Lilly, among others. The article serves as a market roundup without providing specific details on the direction or magnitude of each move. No individual company news or catalysts are elaborated upon in the available text.
Sentiment 0.00LLY - Benzinga4/24/2026, 11:31:33 AMTACO Trade Joke No More? Trump's Art Of The Deal' Powers S&P 500's Steepest Highs And Lows
Fundstrat analysis shows Trump's policy decisions and social media posts are the primary driver of S&P 500 performance in his second term, with the five best market days linked to tariff pauses and Iran war signals and the five worst tied to tariff escalations. Without the five best days, the S&P 500 would be down 2.7% rather than up 19% since Trump took office. The so-called 'TACO trade' (Trump Always Chickens Out) has become a dominant framework for how investors are positioning around rapidly shifting policy signals.
Sentiment 0.10PFE - Yahoo4/24/2026, 11:08:00 AMUnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements
UnitedHealthcare announced it will include more than 50% of its prior authorization volume in an industrywide standardization effort for electronic prior authorization, rising to over 70% by end of 2026. The initiative aims to simplify submission requirements for care providers and improve patient access to care. This is framed as a continuation of the company's broader push to modernize prior authorization processes.
Sentiment 0.20UNH - Yahoo4/24/2026, 11:03:55 AMA $900,000 Stock Portfolio Exposed to Just Three Sectors Is a Retirement Time Bomb
A Yahoo Finance opinion piece warns that a $900,000 retirement portfolio concentrated in only three sectors — tech (45%), healthcare (30%), and financials (25%) — poses significant risk for a 63-year-old investor. The five holdings cited are Apple, Microsoft, Johnson & Johnson, UnitedHealth Group, and JPMorgan Chase. The article frames the lack of diversification as a "retirement time bomb," implying vulnerability to simultaneous sector drawdowns.
- Yahoo4/24/2026, 10:46:00 AMLilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
Eli Lilly shares fell as its obesity drug Foundayo showed a weaker early commercial trajectory compared to oral Wegovy, while Novo Nordisk shares climbed on the contrast. Regeneron announced a drug pricing deal, and two unspecified companies disclosed leadership changes. The FDA also announced plans to issue vouchers related to psychedelic treatments.
Sentiment -0.30LLY - Benzinga4/24/2026, 7:13:57 AMUnitedHealthcare Expects More Than 70% Of Prior Authorization Volume To Be Part Of New Standardized Submission Process By Year‑End
UnitedHealthcare announced that more than 70% of its prior authorization volume is expected to be part of a new standardized submission process by year-end, as part of an industrywide effort. This is the latest in a series of company actions aimed at simplifying and reducing administrative requirements. The move signals a continued operational shift toward streamlining prior authorization workflows.
Sentiment 0.30UNH - Yahoo4/23/2026, 11:41:23 PM2 Healthcare Stocks Worth Your Attention and 1 We Ignore
An article identifies two healthcare stocks as attractive and one to avoid, set against a backdrop of sector underperformance. The healthcare industry has returned 1.8% over the past six months, trailing the S&P 500 by 3.1 percentage points, partly due to post-COVID inventory normalization headwinds in 2023–2024. UNH is the only ticker explicitly tagged to the article.
Sentiment 0.00UNH - Yahoo4/23/2026, 10:23:00 PMThese Companies Are Raising Guidance This Earnings Season
UnitedHealth Group (UNH) and Quest Diagnostics (DGX) both raised their full-year guidance during the current earnings season. Both stocks saw positive post-earnings price reactions following the announcements.
Sentiment 0.70UNH - Yahoo4/23/2026, 8:34:00 PMTop Research Reports for UnitedHealth, Morgan Stanley & RTX
Zacks has released new research reports covering UnitedHealth Group (UNH), Morgan Stanley (MS), and RTX Corporation (RTX), focusing on cost pressures, capital markets performance, and defense sector demand. The reports highlight key themes including UNH's cost navigation, MS's capital markets strength, and RTX's defense demand dynamics. No specific ratings or price targets are detailed in the article.
Sentiment 0.10UNH - Yahoo4/23/2026, 6:41:00 PMHims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing.
Hims & Hers Health is pivoting away from GLP-1 compounding, announcing it will allow providers to prescribe scripts filled through LillyDirect, Eli Lilly's direct-to-consumer platform. The move marks a strategic retreat from compounded GLP-1 drugs, which had been a key growth driver for the company. The stock is falling on the news, as the so-called "Netflix" argument — that Hims could build a subscription-based weight-loss platform — loses credibility.
Sentiment -0.65LLY - Yahoo4/23/2026, 3:53:00 PMHims Stock Drops on LillyDirect Deal. Can It Be the Netflix of Pharma?
Hims & Hers Health announced it will allow providers on its platform to prescribe medications fulfilled through LillyDirect, Eli Lilly's direct-to-consumer pharmacy service. The deal signals a shift in Hims & Hers' business model toward partnering with branded drug manufacturers rather than competing solely on compounded or generic alternatives. Hims stock dropped on the news, likely reflecting concerns about margin pressure or competitive dynamics.
Sentiment -0.40LLY - The Motley Fool4/21/2026, 10:01:20 PMStock Market Today, April 21: Markets in Wait-and-See Mode as Hopes for New U.S.-Iran Peace Talks Fade
Major U.S. indices (S&P 500, Nasdaq, Dow Jones) each fell roughly 0.6% on April 21, 2026, pressured by geopolitical uncertainty surrounding U.S.-Iran tensions and restricted Strait of Hormuz traffic. UnitedHealth Group rose on strong earnings, while GE Aerospace and RTX declined despite beating estimates. Apple and Tesla also sold off amid leadership transition news and pre-earnings uncertainty, respectively.
Sentiment -0.30UNH - Benzinga4/21/2026, 6:47:35 PMS&P 500 Eases On Iran Ceasefire Jitters, Crude Soars To $90: Stock Market Today
The S&P 500 fell 0.3% midday Tuesday as crude oil surged 2.7% to $90/barrel on uncertainty surrounding Iran ceasefire negotiations. Energy stocks outperformed while gold miners (GDX) and airlines (JETS) declined sharply amid rising Treasury yields and geopolitical tensions. Strong retail sales and ADP payroll data showed consumer resilience but raised concerns about further rate hikes.
Sentiment -0.20UNH - Investing.com4/20/2026, 2:29:00 PMQ1 Earnings Kick Off: Strong Results and Record CEO Confidence Anchor the Market
Q1 2026 earnings season is tracking 13.2% S&P 500 earnings growth, marking a sixth consecutive quarter of double-digit expansion. Major banks including Goldman Sachs, JPMorgan, Bank of America, Morgan Stanley, and Wells Fargo reported solid results with investment banking rebounds. Semiconductor names TSM and ASML posted record revenues on AI infrastructure demand, while TSLA, INTC, IBM, and UNH are among other notable reporters this season.
Sentiment 0.70UNH - Investing.com4/12/2026, 2:15:00 PM1 Stock to Buy, 1 Stock to Sell This Week: Netflix, Johnson & Johnson
The S&P 500 posted a 3.6% weekly gain, its best since November, ahead of earnings season. Netflix (NFLX) is highlighted as a buy candidate going into Q1 earnings, citing expected strong revenue growth and positive technical momentum. Johnson & Johnson (JNJ) is flagged as a sell due to analyst downgrades, loss of product exclusivity, and weakening technical indicators.
Sentiment 0.10JNJ - The Motley Fool4/10/2026, 7:15:00 PMHere's Why Buying This Vanguard Index Fund Today Could Be the Best Financial Decision You Ever Make
The Motley Fool publishes a promotional piece advocating for the Vanguard S&P 500 ETF (VOO) as a long-term, low-cost investment vehicle. The article highlights the S&P 500's historical resilience across market crises and its index reconstitution mechanism as key advantages over active trading. Several S&P 500 constituent stocks — including AMZN, GOOG/GOOGL, MSFT, V, MA, LLY, and PLTR — are cited as examples of the index's holdings.
Sentiment 0.30LLY